Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Sep 2;136(1):21–34. doi: 10.1007/s10549-012-2224-0

Fig. 6.

Fig. 6

NF-κB expression and activity in BT474 cells. (a) Effect of Pg on NF-κB and pNF-κB protein levels and (b) luciferase activity in a plasmid containing a NF-κB binding site in the luc-promoter region. Cells were treated with solvent DMSO (control) or different concentration of Pg (2.5–10 µg/ml) for 24h. Effects of (c) miR-155 antagomers (Ant.) and (d) miR-27a antagomers (Ant.) on luciferase activity of the NF-κB promoter construct. Luciferase activity is expressed as ratio to β-gal. All experiments were performed as described in the material and method section and were performed at least three times, and result were expressed as mean ± SE.* indicates significant changes at p<0.05.